CathetersDisclaimer:
These products have not been cleared by the FDA for sale in the United States.
“Much in the same way that high CO2 levels are harmful to our planet, CO2 accumulation in the blood can be even more deadly. CO2 removal through the blood provides the lungs a bridge to recovery that is not possible through mechanical ventilation.”
In 1990 Avalon began its mission to deliver superior cardiopulmonary support cannulae to the world's leading health care providers. Now almost 20 years later, that mission continues with the launch of Avalon Elite™. Avalon Elite™ is a premium brand of catheters designed with advanced materials, innovative engineering and broad proprietary manufacturing technologies. The new Avalon Elite™ line will provide a superior product and help facilitate better care for patients suffering from debilitating diseases.
Lung disease is the number 3 killer of all Americans and one of the most rapidly expanding causes of death in the world. In all other cases of organ failure the course of treatment is to provide rest for the failing organ. The rest allows the organ the best chance for recovery. Only in lung failure do we force the organ to work harder by using mechanical ventilation to pump in high tidal volumes to provide O2 and remove CO2 from the blood.
New alternatives to this potentially damaging treatment have begun to emerge and the next 5 years promise to bring even greater innovation in intravascular extracoporeal therapies. Avalon is ready to provide enabling connections to these important new alternatives to traditional ventilation.
Disclaimer: These products have not been cleared by the FDA for sale in the United States.
Lung disease is the number 3 killer of all Americans and one of the most rapidly expanding causes of death in the world. In all other cases of organ failure the course of treatment is to provide rest for the failing organ. The rest allows the organ the best chance for recovery. Only in lung failure do we force the organ to work harder by using mechanical ventilation to pump in high tidal volumes to provide O2 and remove CO2 from the blood.
New alternatives to this potentially damaging treatment have begun to emerge and the next 5 years promise to bring even greater innovation in intravascular extracoporeal therapies. Avalon is ready to provide enabling connections to these important new alternatives to traditional ventilation.
Disclaimer: These products have not been cleared by the FDA for sale in the United States.
